These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26923192)

  • 1. Attenuation of Postischemic Genomic Alteration by Mesenchymal Stem Cells: a Microarray Study.
    Choi C; Oh SH; Noh JE; Jeong YW; Kim S; Ko JJ; Kim OJ; Song J
    Mol Cells; 2016 Apr; 39(4):337-44. PubMed ID: 26923192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparsion between Intravenous Delivered Human Fetal Bone Marrow Mesenchymal Stromal Cells and Mononuclear Cells in the Treatment of Rat Cerebral Infarct.
    Huang AH; Zhang PP; Zhang B; Ma BQ; Guan YQ; Zhou YD
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Oct; 38(5):497-506. PubMed ID: 27825404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplantation of human mesenchymal stem cells promotes functional improvement and increased expression of neurotrophic factors in a rat focal cerebral ischemia model.
    Wakabayashi K; Nagai A; Sheikh AM; Shiota Y; Narantuya D; Watanabe T; Masuda J; Kobayashi S; Kim SU; Yamaguchi S
    J Neurosci Res; 2010 Apr; 88(5):1017-25. PubMed ID: 19885863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovery of neurological function of ischemic stroke by application of conditioned medium of bone marrow mesenchymal stem cells derived from normal and cerebral ischemia rats.
    Tsai MJ; Tsai SK; Hu BR; Liou DY; Huang SL; Huang MC; Huang WC; Cheng H; Huang SS
    J Biomed Sci; 2014 Jan; 21(1):5. PubMed ID: 24447306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotection by mesenchymal stem cell (MSC) administration is enhanced by local cooling infusion (LCI) in ischemia.
    Wei W; Wu D; Duan Y; Elkin KB; Chandra A; Guan L; Peng C; He X; Wu C; Ji X; Ding Y
    Brain Res; 2019 Dec; 1724():146406. PubMed ID: 31454517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow-mesenchymal stem cells modulate microglial activation in the peri-infarct area in rats during the acute phase of stroke.
    Li Z; Ye H; Cai X; Sun W; He B; Yang Z; Xu P
    Brain Res Bull; 2019 Nov; 153():324-333. PubMed ID: 31589902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cells with modafinil (gold nanoparticles) significantly improves neurological deficits in rats after middle cerebral artery occlusion.
    Nazarian S; Abdolmaleki Z; Torfeh A; Shirazi Beheshtiha SH
    Exp Brain Res; 2020 Nov; 238(11):2589-2601. PubMed ID: 32886135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomes derived from bone marrow mesenchymal stem cells harvested from type two diabetes rats promotes neurorestorative effects after stroke in type two diabetes rats.
    Venkat P; Zacharek A; Landschoot-Ward J; Wang F; Culmone L; Chen Z; Chopp M; Chen J
    Exp Neurol; 2020 Dec; 334():113456. PubMed ID: 32889008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast Growth Factor Type 1 (FGF1)-Overexpressed Adipose-Derived Mesenchaymal Stem Cells (AD-MSC
    Ghazavi H; Hoseini SJ; Ebrahimzadeh-Bideskan A; Mashkani B; Mehri S; Ghorbani A; Sadri K; Mahdipour E; Ghasemi F; Forouzanfar F; Hoseini A; Pasdar AR; Sadeghnia HR; Ghayour-Mobarhan M
    Stem Cell Rev Rep; 2017 Oct; 13(5):670-685. PubMed ID: 28795363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human mesenchymal stem cell transplantation changes proinflammatory gene expression through a nuclear factor-κB-dependent pathway in a rat focal cerebral ischemic model.
    Wang H; Nagai A; Sheikh AM; Liang XY; Yano S; Mitaki S; Ishibashi Y; Kobayashi S; Kim SU; Yamaguchi S
    J Neurosci Res; 2013 Nov; 91(11):1440-9. PubMed ID: 23996632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of different doses of bone marrow-derived mesenchymal stem cells improve post-stroke neurological outcomes via intravenous transplantation.
    Chen Y; Peng D; Li J; Zhang L; Chen J; Wang L; Gao Y
    Brain Res; 2023 Jan; 1798():148161. PubMed ID: 36379315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional cultured mesenchymal stem cells enhance repair of ischemic stroke through inhibition of microglia.
    Li Y; Dong Y; Ran Y; Zhang Y; Wu B; Xie J; Cao Y; Mo M; Li S; Deng H; Hao W; Yu S; Wu Y
    Stem Cell Res Ther; 2021 Jun; 12(1):358. PubMed ID: 34154653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated brain derived neurotrophic factor levels in plasma reflect in vivo functional viability of infused mesenchymal stem cells for stroke in rats.
    Nakamura H; Sasaki Y; Sasaki M; Kataoka-Sasaki Y; Oka S; Nakazaki M; Namioka T; Namioka A; Onodera R; Suzuki J; Nagahama H; Mikami T; Wanibuchi M; Kocsis JD; Honmou O
    J Neurosurg Sci; 2019 Feb; 63(1):42-49. PubMed ID: 28181779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intravenous administration of allogenic bone marrow- and adipose tissue-derived mesenchymal stem cells on functional recovery and brain repair markers in experimental ischemic stroke.
    Gutiérrez-Fernández M; Rodríguez-Frutos B; Ramos-Cejudo J; Teresa Vallejo-Cremades M; Fuentes B; Cerdán S; Díez-Tejedor E
    Stem Cell Res Ther; 2013 Jan; 4(1):11. PubMed ID: 23356495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous Injection of Clinical Grade Human MSCs After Experimental Stroke: Functional Benefit and Microvascular Effect.
    Moisan A; Favre I; Rome C; De Fraipont F; Grillon E; Coquery N; Mathieu H; Mayan V; Naegele B; Hommel M; Richard MJ; Barbier EL; Remy C; Detante O
    Cell Transplant; 2016 Dec; 25(12):2157-2171. PubMed ID: 26924704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenously Delivered Allogeneic Mesenchymal Stem Cells Bidirectionally Regulate Inflammation and Induce Neurotrophic Effects in Distal Middle Cerebral Artery Occlusion Rats Within the First 7 Days After Stroke.
    Li X; Huang M; Zhao R; Zhao C; Liu Y; Zou H; Chen L; Guan Y; Zhang YA
    Cell Physiol Biochem; 2018; 46(5):1951-1970. PubMed ID: 29719282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astrocytes constitute the major TNF-α-producing cell population in the infarct cortex in dMCAO rats receiving intravenous MSC infusion.
    Guan Y; Wang R; Li X; Zou H; Yu W; Liang Z; Li L; Chen L; Zhou L; Chen Z
    Biomed Pharmacother; 2021 Oct; 142():111971. PubMed ID: 34343893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-Arterial Transplantation of Allogeneic Mesenchymal Stem Cells Mounts Neuroprotective Effects in a Transient Ischemic Stroke Model in Rats: Analyses of Therapeutic Time Window and Its Mechanisms.
    Toyoshima A; Yasuhara T; Kameda M; Morimoto J; Takeuchi H; Wang F; Sasaki T; Sasada S; Shinko A; Wakamori T; Okazaki M; Kondo A; Agari T; Borlongan CV; Date I
    PLoS One; 2015; 10(6):e0127302. PubMed ID: 26075717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Exosomal MicroRNA Profile Is Responsible for the Mesenchymal Stromal Cell Transplantation-Induced Improvement of Functional Recovery after Stroke in Rats.
    Huang L; Hua L; Zhang X
    Neuroimmunomodulation; 2022; 29(2):151-160. PubMed ID: 34569545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model.
    Kurozumi K; Nakamura K; Tamiya T; Kawano Y; Ishii K; Kobune M; Hirai S; Uchida H; Sasaki K; Ito Y; Kato K; Honmou O; Houkin K; Date I; Hamada H
    Mol Ther; 2005 Jan; 11(1):96-104. PubMed ID: 15585410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.